NEXT CENTURY GROWTH INVESTORS LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 151 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEXT CENTURY GROWTH INVESTORS LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2015$22,264,000
-0.8%
777,668
-1.4%
0.96%
+3.1%
Q3 2015$22,441,000
+17.9%
788,534
+48.9%
0.93%
+42.3%
Q2 2015$19,028,000
+19.6%
529,743
+93.6%
0.66%
+17.2%
Q1 2015$15,904,000273,5940.56%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders